D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 84 Citations 29,080 268 World Ranking 9923 National Ranking 5243

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Surgery

His primary scientific interests are in Myocardial infarction, Internal medicine, Cardiology, Surgery and Angioplasty. The concepts of his Myocardial infarction study are interwoven with issues in Electrocardiography, Anesthesia, Chest pain and Hazard ratio. His Electrocardiography research integrates issues from ST segment and Infarction.

His Internal medicine study frequently involves adjacent topics like Triage. His Cardiology study incorporates themes from Odds ratio and Confidence interval. His research investigates the link between Surgery and topics such as Tissue plasminogen activator that cross with problems in Plasminogen activator and Fibrinolytic agent.

His most cited work include:

  • 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) (1522 citations)
  • Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. (1065 citations)
  • Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Results From an International Trial of 41 021 Patients (990 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Myocardial infarction, Cardiology, Surgery and Thrombolysis. His Myocardial infarction research incorporates themes from Electrocardiography, Angioplasty, Emergency medicine and Intensive care medicine. His Emergency medicine research includes elements of Emergency department, Conventional PCI and Medical emergency.

In the subject of general Cardiology, his work in Heart failure, Percutaneous coronary intervention, ST segment and TIMI is often linked to In patient, thereby combining diverse domains of study. His Surgery research is multidisciplinary, relying on both Tissue plasminogen activator, Clinical trial and Angina. The Thrombolysis study combines topics in areas such as Fibrinolysis and Fibrinolytic agent.

He most often published in these fields:

  • Internal medicine (67.13%)
  • Myocardial infarction (67.82%)
  • Cardiology (62.98%)

What were the highlights of his more recent work (between 2005-2019)?

  • Internal medicine (67.13%)
  • Cardiology (62.98%)
  • Myocardial infarction (67.82%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI are his primary areas of study. W. Douglas Weaver brings together Internal medicine and In patient to produce work in his papers. His research on Cardiology often connects related areas such as Surgery.

His Myocardial infarction study integrates concerns from other disciplines, such as Stroke, Randomized controlled trial and Hazard ratio. His research in Percutaneous coronary intervention intersects with topics in Coronary angiography, Anesthesia and Radiology. His Conventional PCI study combines topics in areas such as Cardiogenic shock, Intensive care medicine, Triage, Emergency medicine and Quality management.

Between 2005 and 2019, his most popular works were:

  • Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology (753 citations)
  • Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis (408 citations)
  • Acute coronary care in the elderly, Part I Non-ST-segment-elevation acute coronary syndromes a scientific statement for healthcare professionals from the american heart association council on clinical cardiology (394 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Myocardial infarction
  • Surgery

W. Douglas Weaver focuses on Myocardial infarction, Percutaneous coronary intervention, Cardiology, Internal medicine and Conventional PCI. His studies deal with areas such as Relative risk, Randomized controlled trial, Fibrinolytic agent and Emergency medicine as well as Myocardial infarction. When carried out as part of a general Percutaneous coronary intervention research project, his work on Cangrelor is frequently linked to work in In patient, therefore connecting diverse disciplines of study.

Cardiology and Surgery are commonly linked in his work. His study in Hazard ratio, Clinical endpoint, Unstable angina, Angioplasty and Heart failure is carried out as part of his studies in Internal medicine. The study incorporates disciplines such as Psychological intervention, Data quality, Quality management and Intensive care medicine in addition to Conventional PCI.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

Thomas J. Ryan;Elliott M. Antman;Neil H. Brooks;Robert M. Califf.
Journal of the American College of Cardiology (1996)

2432 Citations

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

Cannon Cp;Gibson Cm;Lambrew Ct;Shoultz Da.
JAMA (2000)

1551 Citations

ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction

Thomas J. Ryan;Jeffrey L. Anderson;Elliott M. Antman.
Journal of the American College of Cardiology (1996)

1517 Citations

Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Results From an International Trial of 41 021 Patients

Kerry L. Lee;Lynn H. Woodlief;Eric J. Topol;W. Douglas Weaver.
Circulation (1995)

1417 Citations

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong.
Circulation (2007)

1224 Citations

Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

Peter A McCullough;Edward F Philbin;John A Spertus;Scott Kaatz.
Journal of the American College of Cardiology (2002)

699 Citations

Darapladib for preventing ischemic events in stable coronary heart disease.

Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka.
The New England Journal of Medicine (2014)

606 Citations

Acute coronary care in the elderly, Part I Non-ST-segment-elevation acute coronary syndromes a scientific statement for healthcare professionals from the american heart association council on clinical cardiology

Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong.
Circulation (2007)

602 Citations

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Lars Wallentin;Robert G Wilcox;W Douglas Weaver;Håkan Emanuelsson.
The Lancet (2003)

514 Citations

A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study

Cindy L Grines;Donald R Westerhausen;Lorelei L Grines;J.Timothy Hanlon.
Journal of the American College of Cardiology (2002)

498 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing W. Douglas Weaver

Harlan M. Krumholz

Harlan M. Krumholz

Yale University

Publications: 200

Robert M. Califf

Robert M. Califf

Duke University

Publications: 193

Christopher B. Granger

Christopher B. Granger

Duke University

Publications: 178

Harvey D. White

Harvey D. White

Auckland City Hospital

Publications: 162

Christopher P. Cannon

Christopher P. Cannon

Brigham and Women's Hospital

Publications: 158

Paul W. Armstrong

Paul W. Armstrong

University of Alberta

Publications: 152

Eric J. Topol

Eric J. Topol

Scripps Research Institute

Publications: 135

Elliott M. Antman

Elliott M. Antman

Brigham and Women's Hospital

Publications: 121

Frans Van de Werf

Frans Van de Werf

KU Leuven

Publications: 119

Eric D. Peterson

Eric D. Peterson

The University of Texas Southwestern Medical Center

Publications: 116

C. Michael Gibson

C. Michael Gibson

Beth Israel Deaconess Medical Center

Publications: 114

E. Magnus Ohman

E. Magnus Ohman

Duke University

Publications: 108

John A. Spertus

John A. Spertus

University of Missouri–Kansas City

Publications: 102

Eugene Braunwald

Eugene Braunwald

Harvard Medical School

Publications: 100

Matthew T. Roe

Matthew T. Roe

Duke University

Publications: 99

Lars Wallentin

Lars Wallentin

Uppsala University

Publications: 96

Trending Scientists

David Sánchez

David Sánchez

Rovira i Virgili University

Zhen-Yu Chen

Zhen-Yu Chen

Chinese University of Hong Kong

Daniel Mandler

Daniel Mandler

Hebrew University of Jerusalem

Jing Wei

Jing Wei

Xi'an Jiaotong University

Manuel Toledano

Manuel Toledano

University of Granada

Anastasio Argüello

Anastasio Argüello

University of Las Palmas de Gran Canaria

Mitsue Miyao

Mitsue Miyao

Tohoku University

Maria Giovanna Riparbelli

Maria Giovanna Riparbelli

University of Siena

Mark Morrison

Mark Morrison

University of Queensland

Poul Løgstrup Bjerg

Poul Løgstrup Bjerg

Technical University of Denmark

Paul E. Gessler

Paul E. Gessler

University of Idaho

Donald W. Hine

Donald W. Hine

University of New England

Paul Rohde

Paul Rohde

Oregon Research Institute

Ian B. Wilkinson

Ian B. Wilkinson

University of Cambridge

Vivianne H.M. Visschers

Vivianne H.M. Visschers

University of Applied Sciences and Arts Northwestern Switzerland

William F. Shughart

William F. Shughart

Utah State University

Something went wrong. Please try again later.